Center for the Translational Neuroscience of Alcoholism

$86,562P50FY2015AANIH

Yale University, New Haven CT

Investigators

Linked publications & trials

Paper 39532676 Paper 39316635 Paper 39242922 Paper 39214852 Paper 39145449 Paper 39005401 Paper 38629811 Paper 38383808 Paper 38102794 Paper 38062264 Paper 37790400 Paper 37756443 Paper 37662268 Paper 37605827 Paper 37488280 Paper 37141764 Paper 36747741 Paper 36577721 Paper 36536243 Paper 35389087 Paper 35342968 Paper 35151022 Paper 34920884 Paper 34498528 Paper 34475522 Paper 34313217 Paper 34226506 Paper 34211176 Paper 34124712 Paper 34060870 Paper 33958034 Paper 33605439 Paper 33587295 Paper 33554217 Paper 33506530 Paper 33254081 Paper 33179331 Paper 32919411 Paper 32792052 Paper 32585343 Paper 32541931 Paper 32459295 Paper 32451486 Paper 32405077 Paper 32363592 Paper 32354856 Paper 32352581 Paper 32249311 Paper 32068323 Paper 31892465 Paper 31759072 Paper 31693193 Paper 31590179 Paper 31385647 Paper 31253468 Paper 31202048 Paper 31193836 Paper 31123390 Paper 31056846 Paper 30946828 Paper 30844397 Paper 30817018 Paper 30711509 Paper 30589475 Paper 30488612 Paper 30388593 Paper 30355445 Paper 30297031 Paper 30287806 Paper 30188515 Paper 30138015 Paper 30134085 Paper 29859929 Paper 29803635 Paper 29609132 Paper 29580271 Paper 29499855 Paper 29498753 Paper 29484671 Paper 29450895 Paper 29304425 Paper 29230810 Paper 29172227 Paper 29131352 Paper 29118216 Paper 29092750 Paper 29087817 Paper 28990359 Paper 28974459 Paper 28844076 Paper 28434616 Paper 28432340 Paper 28418321 Paper 28413777 Paper 28349588 Paper 28336571 Paper 28327175 Paper 28265120 Paper 28189575 Paper 28187187

Abstract

DESCRIPTION (provided by applicant): The gap between basic research advances and new clinical insights and treatments remains a critical obstacle to progress in the field of alcoholism research. This translational neuroscience mission is the enduring focus of the Center for the Translational Neuroscience of Alcoholism (CTNA). CTNA conducts groundbreaking molecular neuroscience, molecular genetics, functional and chemical neuroimaging, and psychopharmacology studies in the service of providing new insights to bridge the gap between basic and clinical research. This renewal application will study mechanisms through which disturbances in glutamate and dopamine neurotransmission within cortico-limbic circuitry promote the development of pathological drinking. Building on this perspective and its prior achievements, CTNA will explore novel approaches to the pharmacotherapy of alcoholism. CTNA will facilitate transdisciplinary research within projects and across projects. It will also continue its highly productive Pilot Projects Core that provides an open competitive mechanism to enable the Center to rapidly encompass innovative new research and to engage outstanding investigators new to alcoholism research. CTNA will continue to expand its educational mission, building on the success of the NIAAA Research Fellowship and the International Conference on the Applications of Neuroimaging to Alcoholism.

View original record on NIH RePORTER →